Ownership history in MATHER GROUP, LLC. · 5 quarters on record
This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 132 | — | 0% | 0.00% | $3K | $19.70 |
| 2025 Q1 | UNCHANGED | 132 | — | 0% | 0.00% | $3K | $24.25 |
| 2024 Q4 | UNCHANGED | 132 | — | 0% | 0.00% | $3K | $20.87 |
| 2024 Q3 | REDUCED | 132 | -333 | -71.6% | 0.00% | $3K | $19.88 |
| 2024 Q2 | INITIATED | 465 | — | — | 0.00% | $7K | — |
As of 2025 Q4 — sorted by position size